These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12963898)

  • 61. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
    Thiboutot DM; Weiss J; Bucko A; Eichenfield L; Jones T; Clark S; Liu Y; Graeber M; Kang S;
    J Am Acad Dermatol; 2007 Nov; 57(5):791-9. PubMed ID: 17655969
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions.
    Feldman SR; Tan J; Poulin Y; Dirschka T; Kerrouche N; Manna V
    J Am Acad Dermatol; 2011 Jun; 64(6):1085-91. PubMed ID: 21439678
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study.
    Bissonnette R; Poulin Y; Drew J; Hofland H; Tan J
    J Am Acad Dermatol; 2017 Jan; 76(1):33-39. PubMed ID: 28029390
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials.
    Eichenfield LF; Lain T; Frankel EH; Jones TM; Chang-Lin JE; Berk DR; Ruan S; Kaoukhov A
    J Drugs Dermatol; 2016 Aug; 15(8):962-9. PubMed ID: 27537997
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
    Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Chavda R; Kerrouche N; Tan J
    Am J Clin Dermatol; 2019 Oct; 20(5):725-732. PubMed ID: 31209851
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety.
    Eichenfield LE; Jorizzo JL; Dirschka T; Taub AF; Lynde C; Graeber M; Kerrouche N
    J Drugs Dermatol; 2010 Nov; 9(11):1395-401. PubMed ID: 21061762
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study.
    Kobayashi M; Nakagawa T; Fukamachi K; Nakamura M; Tokura Y
    J Dermatol; 2011 Dec; 38(12):1163-6. PubMed ID: 22007904
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-Inflammatory Dose Doxycycline Plus Adapalene 0.3% and Benzoyl Peroxide 2.5% Gel for Severe Acne.
    Kircik LH
    J Drugs Dermatol; 2019 Sep; 18(9):924-927. PubMed ID: 31524349
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
    Guerra-Tapia A
    J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
    Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
    Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
    Cunliffe WJ; Poncet M; Loesche C; Verschoore M
    Br J Dermatol; 1998 Oct; 139 Suppl 52():48-56. PubMed ID: 9990421
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Polarized light photography and videomicroscopy greatly enhance the capability of estimating the therapeuic response to a topical retinoid (adapalene) in acne vulgaris.
    Rizova E; Pagnoni PA; Stoudemayer T; Poncet M; Kligman AM
    Cutis; 2001 Oct; 68(4 Suppl):25-33. PubMed ID: 11845945
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
    Kakita L
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S51-4. PubMed ID: 10898831
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.
    Andres P; Pernin C; Poncet M
    Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients.
    Tan J; Gollnick HP; Loesche C; Ma YM; Gold LS
    J Dermatolog Treat; 2011 Aug; 22(4):197-205. PubMed ID: 20666678
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel.
    Chularojanamontri L; Tuchinda P; Kulthanan K; Varothai S; Winayanuwattikun W
    J Dermatolog Treat; 2016; 27(2):140-5. PubMed ID: 26293170
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: A Safe and Effective Acne Therapy in All Skin Phototypes.
    Alexis AF; Cook-Bolden FE; York JP
    J Drugs Dermatol; 2017 Jun; 16(6):574-581. PubMed ID: 28686775
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne.
    Brogden RN; Goa KE
    Drugs; 1997 Mar; 53(3):511-9. PubMed ID: 9074847
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris.
    Del Rosso JQ
    J Drugs Dermatol; 2007 Jun; 6(6):616-22. PubMed ID: 17668527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.